As of January 22, 2025, Corcept Therapeutics (CORT) has a market cap of $6.16 billion USD. According to our data, Corcept Therapeutics is ranked No.2352 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $6.16 B |
16.77%
|
Dec 31, 2024 | $5.28 B |
55.14%
|
Dec 29, 2023 | $3.40 B |
59.92%
|
Dec 30, 2022 | $2.13 B |
2.58%
|
Dec 31, 2021 | $2.07 B |
-24.31%
|
Dec 31, 2020 | $2.74 B |
116.20%
|
Dec 31, 2019 | $1.27 B |
-9.43%
|
Dec 31, 2018 | $1.40 B |
-26.02%
|
Dec 29, 2017 | $1.89 B |
148.76%
|
Dec 30, 2016 | $0.76 B |
45.78%
|
Dec 31, 2015 | $0.52 B |
66.00%
|
Dec 31, 2014 | $0.31 B |
-6.54%
|
Dec 31, 2013 | $0.34 B |
124.48%
|
Dec 31, 2012 | $0.15 B |
-58.19%
|
Dec 30, 2011 | $0.36 B |
-11.40%
|
Dec 31, 2010 | $0.40 B |
38.85%
|
Dec 31, 2009 | $0.29 B |
172.55%
|
Dec 31, 2008 | $0.11 B |
-66.99%
|
Dec 31, 2007 | $0.32 B |
151.22%
|
Dec 29, 2006 | $0.13 B |
-66.30%
|
Dec 30, 2005 | $0.38 B |
-41.60%
|
Dec 31, 2004 | $0.65 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Teva Pharmaceutical Industries
TEVA
|
$25.08 B |
19.908 M
|
Israel
|
Alkermes
ALKS
|
$4.90 B |
0.000 M
|
Ireland
|
Jazz Pharmaceuticals
JAZZ
|
$7.35 B |
-0.000 M
|
Ireland
|
Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
Sage Therapeutics
SAGE
|
$0.43 B |
0.000 M
|
USA
|
Biohaven Pharmaceutical
BHVN
|
$4.09 B |
0.000 M
|
USA
|
Intra-Cellular Therapies
ITCI
|
$13.51 B |
0.000 M
|
USA
|
Supernus Pharmaceuticals
SUPN
|
$2.12 B |
-0.015 B
|
USA
|
Axsome Therapeutics
AXSM
|
$4.90 B |
0.000 M
|
USA
|
ACADIA Pharmaceuticals
ACAD
|
$2.97 B |
-3.328 M
|
USA
|
Amneal Pharmaceuticals
AMRX
|
$3.92 B |
1.290 B
|
USA
|
Ironwood Pharmaceuticals
IRWD
|
$0.60 B |
0.000 M
|
USA
|
Vanda Pharmaceuticals
VNDA
|
$0.26 B |
-0.000 M
|
USA
|
Market Cap | = | CORT Stock Price | * | CORT Shares Outstanding |
= | $58.84 | * | 0.10 B | |
= | $6.16 B |